Why the study?
Post-COVID-19 patients may develop cardiac symptoms, and whether multi-parametric CMR can assess the background of these post-COVID-19 cardiac symptoms remained to be investigated.
Does multi-parametric cardiovascular magnetic resonance identify myocardial inflammation and fibrosis in symptomatic patients with post-COVID-19 syndrome?
Does multi-parametric cardiovascular magnetic resonance identify myocardial inflammation and fibrosis in symptomatic patients with post-COVID-19 syndrome?
Multi-parametric CMR reveals that the majority of patients with post-COVID-19 cardiac symptoms have non-ischemic LGE and T1 abnormalities, with one-third showing active myocardial inflammation (both T1 and T2 criteria) months after infection.
Answers are grounded in this paper and cite their sources.
May support targeted CMR evaluation in symptomatic post-COVID patients; leaves open whether findings alter management or outcomes.
Introduction. Post-coronavirus disease-2019 (COVID-19) patients may develop cardiac symptoms. We hypothesized that cardiovascular magnetic resonance (CMR) can assess the background of post-COVID-19 cardiac symptoms using multi-parametric evaluation. We aimed to conduct an investigation of symptomatic patients with post-COVID-19 syndrome using CMR (INSPIRE-CMR). Methods. INSIPRE-CMR is a retrospective multicenter study including 174 patients from five centers referred for CMR due to cardiac symptoms. CMR was performed using 3.0 T/1.5 T system (24%/76%, respectively). Myocardial inflammation was determined by the updated Lake Louise criteria. Results. Further, 174 patients with median age of 40 years (IQR: 26–54), 72 (41%) were women, and 17 (9.7%) had a history of autoimmune disease, muscular dystrophy, or cancer. In total, 149 (86%) patients were late gadolinium enhanced (LGE)-positive with a non-ischemic pattern, and of those evaluated with the updated Lake Louise criteria, 141/145 (97%) had ≥1 pathologic T1 index. Based on the T2-criterion, 62/173 (36%) patients had ≥1 pathologic T2 index. Collectively, 48/145 (33%) patients had both positive T1- and T2-criterion. A positive T2-criterion or a combination of a positive T1- and T2-criterion were significantly more common amongst patients with severe COVID-19 [45 (31%) vs. 17 (65%), p = 0.001 and 32 (27%) vs. 16 (64%), p < 0.001, respectively]. During the one-year evaluation, available for 65/174 patients, shortness of breath, chest pain, and arrhythmia were identified in 7 (4%), 15 (8.6%), and 43 (24.7%), respectively. CMR evaluation, available in a minority of them, showed mildly reduced LVEF, while nat T1 mapping and EVC remained at levels higher than the normal values of the local MRI units. Conclusions. The majority of post-COVID-19 patients with cardiac symptoms presented non-ischemic LGE and abnormalities in T1 and T2-based indices. Multi-parametric CMR reveals important information on post-COVID-19 patients, supporting its role in short/long-term evaluation.
No takes yet. Share an insight, caveat, or question.
Markousis‐Mavrogenis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: